The aromatase-inhibiting effect of pomegranate extracts was also shown in a placental microsome aromatase test using ellagitannin-derived compounds, such as methylated urolithin A which in turn inhibits the multiplication of breast cancer cells [144]. Here, CYP19A1 is linked to breast cancer.